Your browser doesn't support javascript.
loading
Milestones in tumor vascularization and its therapeutic targeting.
De Palma, Michele; Hanahan, Douglas.
Afiliação
  • De Palma M; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), Lausanne, Switzerland. michele.depalma@epfl.ch.
  • Hanahan D; Agora Cancer Research Center, Lausanne, Switzerland. michele.depalma@epfl.ch.
Nat Cancer ; 5(6): 827-843, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38918437
ABSTRACT
Research into the mechanisms and manifestations of solid tumor vascularization was launched more than 50 years ago with the proposition and experimental demonstrations that angiogenesis is instrumental for tumor growth and was, therefore, a promising therapeutic target. The biological knowledge and therapeutic insights forthcoming have been remarkable, punctuated by new concepts, many of which were not foreseen in the early decades. This article presents a perspective on tumor vascularization and its therapeutic targeting but does not portray a historical timeline. Rather, we highlight eight conceptual milestones, integrating initial discoveries and recent progress and posing open questions for the future.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Neovascularização Patológica Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Neovascularização Patológica Limite: Animals / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article